BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7002785)

  • 1. Reversible inhibition of cell differentiation by phorbol esters as a possible mechanism of the promotion step in chemical carcinogenesis.
    Yamasaki H
    IARC Sci Publ; 1980; (27):91-111. PubMed ID: 7002785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes.
    Weinstein IB; Lee LS; Fisher PB; Mufson A; Yamasaki H
    J Supramol Struct; 1979; 12(2):195-208. PubMed ID: 397370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor promotion in chemical carcinogenesis-inhibition of cell differentiation by phorbol esters (author's transl)].
    Yamasaki H
    Tanpakushitsu Kakusan Koso; 1979; 24(8):999-1009. PubMed ID: 394194
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters.
    Mondal S; Heidelberger C
    Cancer Res; 1980 Feb; 40(2):334-8. PubMed ID: 6153153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host factors in the susceptibility of mice to tumour initiating and promoting agents.
    Slaga TJ
    IARC Sci Publ; 1983; (51):257-73. PubMed ID: 6365772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of phorbol esters on induction of differentiation of mouse myeloid leukemia cells by human urinary protein and lipopolysaccharide.
    Nakayasu M; Shoji M; Aoki N; Sato S; Miwa M; Sugimura T
    Cancer Res; 1979 Nov; 39(11):4668-72. PubMed ID: 291479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.
    Fibach E; Yamasaki H; Weinstein IB; Marks PA; Rifkind RA
    Cancer Res; 1978 Nov; 38(11 Pt 1):3685-8. PubMed ID: 279396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells.
    Yamasaki H; Weinstein IB; Fibach E; Rifkind RA; Marks PA
    Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635
    [No Abstract]   [Full Text] [Related]  

  • 9. Initiator and promoter induced specific changes in epidermal function and biological potential.
    Yuspa SH; Hennings H; Lichti U
    J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular communication, cell differentiation and tumour promotion.
    Yamasaki H; Enomoto T; Martel N
    IARC Sci Publ; 1984; (56):217-38. PubMed ID: 6598800
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
    Dell'Aquila ML; Nguyen HT; Herald CL; Pettit GR; Blumberg PM
    Cancer Res; 1987 Nov; 47(22):6006-9. PubMed ID: 3478136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation.
    Mager D; Bernstein A
    J Cell Physiol; 1980 Dec; 105(3):519-26. PubMed ID: 6936401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation.
    Koeffler HP; Bar-Eli M; Territo MC
    Cancer Res; 1981 Mar; 41(3):919-26. PubMed ID: 6936077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.
    Yamasaki H; Drevon C; Martel N
    Carcinog Compr Surv; 1982; 7():359-77. PubMed ID: 7039831
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cells.
    Srinivas L; Colburn NH
    Cancer Res; 1984 Apr; 44(4):1510-4. PubMed ID: 6608408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
    Colburn NH; Wendel E; Srinivas L
    J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters, part 2.
    Blumberg PM
    Crit Rev Toxicol; 1981 Jun; 8(3):199-234. PubMed ID: 7018838
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of human myeloid leukemic cells by phorbol esters: correlation with tumor promotion.
    Fibach E; Agranat I; Rachmilewitz EA
    Int J Cancer; 1984 Oct; 34(4):451-7. PubMed ID: 6593308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results and speculations related to recent studies on mechanisms of tumor promotion.
    Weinstein IB; Horowitz AD; Mufson RA; Fisher PB; Ivanovic V; Greenebaum E
    Carcinog Compr Surv; 1982; 7():599-616. PubMed ID: 7039835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.